To elucidate serum ANA profile across various lymphoma subtypes and to explore potential value of these autoantibodies in predicting lymphoma outcomes, our research employed enzyme-linked immunosorbent assay (ELISA) for ANA profile detection. This evidence concerns the gene BTG3 and lymphoma.